The British Small Animal Veterinary Association has announced the appointment of Dr Frances Barr as Academic Director, tasked with developing the new BSAVA postgraduate qualification in association with the Open University, ready for launch in 2012.
Frances is a European Specialist in Veterinary Diagnostic Imaging, and a double diplomat of the Royal College of Veterinary Surgeons and the European College of Veterinary Diagnostic Imaging. She has worked both in practice and as an academic, with 26 years working in Higher Education, and has a long history of working as a BSAVA volunteer, eventually taking on the presidential mantle in 2007.
BSAVA says it aims to provide the best possible educational offering to the profession, particularly to those in practice. Grant Petrie, BSAVA President, said: "Producing a postgraduate qualification is a natural progression to BSAVA's current CPD offering - there is clearly a need for it and we have a strong legacy as a provider of quality CPD. We want to make sure that the profession is served well - with a programme designed by vets for vets. As a charity with education at the core of our remit, BSAVA is best positioned to create something that will keep investing in the knowledge and talent of the profession. However, we always knew that we would need an exceptional individual to oversee the programme, and, in Frances Barr, we know we have that person."
Frances said: "This will fill a really important need. Many practitioners have a real appetite for learning more about their particular area of interest. Of course, they can currently do this with general CPD courses, but this new qualification will provide a structured and focussed learning programme which is flexible enough to fit around the busiest lifestyle, yet challenging enough to make the qualification a personal achievement, one that will be well respected by the whole profession."
She added: "The proposed new certificates in small animal medicine and surgery will comprise a combination of traditional taught courses, a wide-range of web-based material that will include interactive sessions, and workplace-based projects. This is the way forward for practitioners and will lead the profession into a more secure future."
The qualifications will be aimed primarily at the general practitioner, so they are not designed to replace the European Diploma system or aspiring to provide specialised knowledge. Instead they will be created very much for the interested, busy practitioner for whom an accredited residency programme is not an option. Grant Petrie said: "Encouraging small animal practitioners to embark on a clinically useful, challenging yet achievable, highly regarded postgraduate qualification sits very well with the BSAVA's remit to promote excellence in small animal practice through education and science."
The BSAVA postgraduate programme will launch in 2012, with more information about registration available at Congress 2011 and online from April next year. Frances Barr will begin working with the Open University and the BSAVA team in November.
Elanco Companion Animal Health has announced that its Duvaxyn IE and IE-T Plus vaccines have been licensed for active immunisation against OIE recommended clade 1 and clade 2 equine influenza strains, the first vaccines to be so licensed.
The company says the updated license is a result of a recent challenge study which demonstrated the ability of Duvaxyn IE-T Plus equine influenza vaccine to induce cross protection against clade 2 strain A/equi-2/Richmond/1/07 (H3N8) two weeks after two doses of the primary course1 were given. Cross-protection was further supported by another study2 measuring serum antibody response to the Richmond '07 strain 52 weeks after the three dose primary vaccination course.
The OIE (World Organisation for Animal Health) updated its equine influenza vaccine recommendations in 2010 to reflect the fact that all field strains characterised through 2008 and 2009 were of clade 1 or 2 of the Florida sub-lineage. The antigenic difference between viruses of these clades could potentially compromise the effectiveness of vaccines containing a representative of a single clade3.
Anna Jackson, national veterinary manager for Elanco Companion Animal Health UK, said: "Whilst no vaccine has been updated to match the current OIE recommendations, the results of our challenge study and subsequent licence update provide reassurance that horses vaccinated with Duvaxyn will be protected against clinical signs of disease caused by currently circulating strains of equine influenza, including those the OIE has identified as being of concern.
"Further reassurance is also given with the confirmation in our study that Duvaxyn IE-T Plus elicits a cell mediated immune response, recognised to play an important role to aid in viral clearance and further enhances protection against strains circulating in the field." 4
The live virus challenge study, conducted by the Animal Health Trust, involved two groups of EIV seronegative horses. The first group, consisting of seven vaccinates, were given two doses of Duvaxyn IE-T Plus, 28 days apart, and challenged with A/equi-2/Richmond/1/07 (H3N8) virus strain 14 days after the second vaccination. The second group of unvaccinated horses was challenged at the same time. Duvaxyn IE-T Plus caused a statistically significant reduction in both clinical signs of the disease and in viral shedding.
Duvaxyn IE-T Plus is the only inactivated whole virus carbomer adjuvanted equine influenza vaccine in the UK. According to Elanco, experts in the field of human vaccination have expressed the view that whole virus vaccines have the potential to induce a stronger and more broadly based response to circulating influenza strains than those contained in sub-unit vaccines because of the presence of the full set of virus proteins including the conserved nucleoprotein, which shows no antigenic drift, in the vaccine5.
References
Equine vets at the Animal Health Trust are appealing to horse riders to help with a research project, to assess the interaction between horse, saddle and rider.
Dr Sue Dyson, Head of Clinical Orthopaedics at the Centre for Equine Studies at the Animal Health Trust and Line Greve, PhD student, are conducting the study to find out how the horse, rider and saddle can influence each other. They are trying to understand better why a saddle may persistently slip to one side in some horses.
Line said: "Saddle slip is a problem seen in all sorts of horses and ponies and can contribute to back pain and thus impaired performance. Research suggests that 25% of British dressage horses have a history of back-related problems and subsequent reduced performance. Our preliminary studies involve just over 700 riders but for a more accurate picture we would like to bump this figure up to 1000 plus. We are urging all riders, whatever their level or ability, to help by completing the questionnaire."
The online questionnaire should take no more than 15 minutes to complete and all answers remain anonymous. The questions cover saddle types, fitting, use and maintenance; rider experience, training and 'handedness'; as well as horse type, use and any previous lameness or back-related problems.
To take part in the study, complete the questionnaire here: http://www.aht.org.uk/cms-display/premise_questionnaire.html. The AHT says that by doing so, you'll be helping to protect and improve the future health, welfare and longevity of the ridden horse.
The results will be presented at the Saddle Research Trust Conference in 2014.
The Kennel Club has announced the results of some research which shows that children's pester power was behind the decision to buy a dog for one in four households1.
One in ten said their children chose the breed or crossbreed that they ended up buying. One in ten also said they buy dogs as presents, something which the Kennel Club highlights as a concern in the run up to Christmas.
The Kennel Club's Discover Dogs survey, which has been conducted to highlight the event of the same name which takes place at Earls Court on 9th and 10th November, has also revealed that too many people are buying a dog without realising that there are great differences between the care needs of the different breeds and crossbreeds. One in ten admitted that they did no research about their chosen breed but bought their puppy because of the way that it looked. A further 40% said that they chose their puppy because they liked the way that the breed looked overall.
According to Kennel Club Breed Rescue organisations, 'wrong breed' and 'can't cope' account for 15% of the dogs that need to be rehomed, a situation that could be easily avoided with the right research2. Only 17% of people in the Kennel Club's Discover Dogs survey say that their choice of dog was influenced by whether it would suit their lifestyle.
To try and address this issue, the Kennel Club has launched a Discover Dogs homework pack for children, to help them to do vital research about dog ownership.
Caroline Kisko, Kennel Club Secretary, said: "Children have a major influence on their parents' decision to buy a dog in the first place, and then over which type of dog they buy. In the lead up to Christmas we want families to be thinking carefully about whether a dog is right for them, and if so which breed would suit their lifestyle, rather than buying on a whim, and this is what the Discover Dogs event is all about.
"We have released the Discover Dogs homework packs to help children get all of the information that they and their parents need to make the right choice about their lifelong companion. This ranges from the type of dog they buy, where they buy it from, and what that dog will need throughout its life."
Children under 12 years old go free to the Kennel Club's Discover Dogs event, where they will be entertained in the Young Kennel Club Kids' Zone with fun dog displays, face painting, treasure hunts and much more.
The Young Kennel Club is open to children aged 6-24 years old and it helps young dog lovers to learn new skills, understand more about dogs, to build confidence and to make new friends. The homework pack can be found at www.discoverdogs.org.uk/buyingadog.
Fidavet has launched Surosolve, a vet wholesaler exclusive, non-prescription ear cleaner for cats and dogs.
Fidavet says the product has multiple uses for complete cat and dog ear cleaning:
Surosolve maintains healthy ears by acting as an antibacterial flush1, 2 and antibiotic potentiating agent2, 3 while contributing to restoring the normal microbiological balance of the ear canal.
According to the company, the product has already received positive feedback from veterinary practitioners that have used it: 79 per cent liked the appearance of the formulation and over 80 per cent appreciated the fragrance.
Helen Goldberg, marketing manager for Janssen Animal Health, said: "Surosolve has a unique, powerful yet non-irritant formulation, ideal for the ears of cats and dogs. This non-irritating solution with an almost neutral pH of 6.8 allows cleaning while respecting natural ear physiology.
"Surosolve also contains Tris-EDTA, which gives extra power to concurrent topical antibiotics. EDTA is a chelating agent, active in damaging the cell surfaces of bacteria, while Tris enhances the effect of EDTA by buffering the pH, ensuring the solution is not irritating to the ear and maximising the anti-bacterial effect."
Marion Lannegrace, Janssen Animal Health international product manager for Fidavet said: "The Fidavet range is only available through veterinary wholesalers because we firmly believe these products should be used only with veterinary advice. This gives clients peace of mind that their pet is receiving the best care."
For further information on Fidavet Surosolve, visit www.fidavet.com.
References:
1 Cole LK. Anatomy and physiology of the canine ear. Veterinary Dermatology, 2010, 20 (5-6), 412-4212 Cole LK, Nuttall TJ. Pseudomonas otitis. Advances in Veterinary Dermatology, Proceedings of the Fifth World Congress of Veterinary Dermatology, 2005, (5), 324-3303 Roberts NA, Gray GW, Wilkinson SC. The bactericidal action of ethylenediaminetetraacetic acid on Pseudomonas aeruginosa. Microbios, 1970, (7-8), 189-208
Merial has highlighted two new studies which the company says demonstrates the efficacy and safety of its canine NSAID, Previcox.
In the first study, Lecoindre and Pepin evaluated the beneficial effects of once daily administration of 5mg/kg Previcox to dogs suffering from osteoarthritis (OA) for 90 days. According to the company, response to treatment was excellent, with significant improvements observed in lameness scores, pain on manipulation of the affected joint and range of motion. Of particular note was the fact that the degree of improvement increased with duration of treatment, clearly demonstrating the benefits of longer term treatment. These results support the findings of a recent review of the safety and efficacy of long-term NSAID use in dogs with OA. The product's safety profile was also evaluated by means of biochemistry and haematology assessments. In addition, regular gastroscopic examinations were used to directly visualise the effect of treatment on the gastric mucosa. These safety assessments demonstrated that Previcox therapy was well tolerated, with no significant treatment related changes seen on biochemistry or gastroscopy, despite the fact that this was a geriatric population which included a number of dogs with a prior history of gastrointestinal tract disease.
Merials says the findings from a different study by Joubert, published in the South African Veterinary Journal, provide further confirmation of the beneficial effects of 90 days Previcox treatment in a geriatric population of dogs.
Commenting on the results of the two studies, Kevin Whelan, Merial's Veterinary Technical Manager said: "The outcome from these studies provide further evidence for the benefits of long term use of Previcox in dogs suffering from osteoarthritis. There is relatively little published information available on the use of NSAIDs in older dogs, and these results confirm that Previcox is well tolerated in this group of patients."
For further information about Previcox, please contact your local Territory Manager or call 0870 6000 123.
Amanda Melvin, Marketing Manager for the Companion Animal Team at MSD Animal Health said: "Research has shown that up to 20% of diabetic pets die, or are euthanised, within a year of diagnosis1 so we want to do everything we can to prevent any further increases in this figure.
"Recent circumstances have put most practices under a great deal of strain and it's become clear from the increase in calls we're receiving that there is a high demand for more information and resources to support the care of diabetic pets.
"We've therefore decided that with Pet Diabetes Month in November, our best way of supporting veterinary practices is to make them aware of, and know how to access the resources we have available to help them."
The diabetes resources include veterinary nurse clinics and training, getting the most out ofVetPen, monitoring support tools and case advice.
Veterinary professionals can subscribe for access to the materials as individuals or as a practice team.
For further information, visit https://www.msd-animal-health-hub.co.uk/ahp/caninsulin/tools.
The review, announced earlier this year, was recommended to RCVS Council by its Standards Committee following its exploration of the implications of new technologies for both animal health and welfare and veterinary regulation.
The main areas under consideration include the provision of 24-hour emergency cover and the interpretation and application of an animal being under the care of a veterinary surgeon.
The initial stages of this review had been drafted for Standards Committee to consider at its meeting on 9 September, where the outline timetable was also discussed.
Standards Committee Chair Melissa Donald, said: "This is set to become one of our most fundamental reviews of RCVS guidance in recent years.
"Considering the complexity of the issues in question, and their importance to animal owners and the professions alike, it is vital that we allow ourselves enough time to ensure this review is as thorough and comprehensive as possible.
"We have a clear responsibility to seek, understand and, where we can, accommodate the opinions and experiences of as many different people from within and around the professions and the public as possible. I would urge my fellow vets and vet nurses to please find some time to consider these issues very carefully over the coming weeks and months, and to send us their views."
The review will comprise several stages and is expected to take around 12 months to complete. The outline timetable, which may be subject to change, is as follows:
October 2019 – January 2020: six-week Call for Evidence, followed by independent qualitative analysis of all evidence received
February – March: Select Committee-style meetings and independent qualitative analysis of additional evidence gathered [NB this stage is subject to Standards Committee requirements, depending on the evidence gathered.]
April – June: Consider all evidence and draft any new policy
July – August: six-week public consultation on draft policy
September – October: independent review of consultation responses, and production of any proposals for change
November 2020: Finalise any proposals for change and publish any new guidance
To support and promote the various stages of the review the College is also planning a programme of stakeholder engagement, and will also provide regular updates on progress to both Council and the wider profession.
Members of the professions and the public will be able to follow the progress of the review via the RCVS website at: www.rcvs.org.uk/undercare
The Working Group, which was formed in January, is chaired by Nigel Gibbens (pictured right) and composed of representatives from BVA specialist divisions and affiliate groups, and others with relevant expertise and knowledge.
As the Association says, the RCVS review will potentially have a far-reaching impact on the future of the veterinary profession, animal health and welfare, and the relationships vets have with their clients.
Of particular concern are the impact of remote prescribing on animal welfare and how limited-service providers (ie those offering online consultations only) will affect the commercial viability of full-service providers.
It is therefore hugely important that the BVA's response represents the opinions and evidence of as many people in the profession as possible.
Information about the BVA Working Group, including the minutes of meetings held so far and the 'themes' document which reflects the group's current thoughts, can be found here: https://www.bva.co.uk/about-us/our-structure/working-groups/
Nigel said: "I encourage you to look at this information carefully, and feed in any evidence that you wish the group to consider along with your thoughts on the content of the BVA response to the RCVS. You can do this via BVA’s Head of Policy & Governance Amelia Findon (ameliaf@bva.co.uk) who will ensure that comments are collated and considered by our group.
"The breadth of opinion across the profession means that the BVA response cannot please everyone, nor should it attempt to. However, it will be based on available evidence and a good understanding of the full scope of views. BVA policy will thus reflect the majority view whilst embracing the positive potential of technological innovations that will inevitably change the way we interact with clients. I urge you to take the time to consider the implications and let us have your thoughts."
VetSurgeon.org has launched a new collaborative publishing section of the website (called a wiki) in which any member of the site may publish case studies and reports, abstracts, short communications, research papers and the results of clinical audit for open discussion and review by all.
The state-of-the-art systems in use on VetSurgeon then allow all members to comment on the work submitted. Initially, it's hoped that this will stimulate valuable further debate, discussion and critical review of papers that have already been published elsewhere. However, another benefit of this system is that it enables anyone in the profession to publish their research to the veterinary community immediately, without being at the mercy of such things as the availability of space in a traditional print journal, so original work is warmly welcomed.
Arlo Guthrie, editor of VetSurgeon said: "Of course I recognise that authors still want the kudos of publication in a traditional peer reviewed journal. However, in addition to offering immediate publication, this system also opens the review process up so that everyone in the profession can participate in a completely open way. If it works, it may even come to be thought of as a more stringent and robust method of review than the traditional method. Or perhaps more likely, peer review could become a two stage process in which work is assessed by a panel of experts and then by the sort of 'open review' offered by VetSurgeon.org."
Doubtless there will be concerns about the validity of information published in this new section of VetSurgeon, primarily because it may NOT have been subject to peer review at the time of publication. Arlo said: "I don't think this is an issue. VetSurgeon members should just have a different starting point. When you read content in, say Vet Record, you can presume it's been scrutinised and read it in that context. On VetSurgeon, you should assume the opposite, and then use the tools offered by the site to judge the value of the work yourself."
Ways of assessing work published on VetSurgeon.org include:
In phase one of this project, taking place over the coming few days, all abstracts published in Veterinary Practice magazine are being uploaded to the new wiki.
Click here to visit the new VetSurgeon Wiki
Colin graduated from the RVC in 1992 and has worked as a clinical veterinary surgeon in a variety of first opinion practices and referral centres. He trained as a veterinary anaesthetist at Bristol and Cambridge Universities before moving into the pharmaceutical industry, gaining experience in drug development and technical support, and pre- and post-marketing, at a number of companies.
Colin said: “Animalcare is introducing a number of new and innovative medicines, such as Daxocox, its weekly NSAID to reduce breakthrough pain in dogs with osteoarthritis, to the veterinary sector. This makes it an exciting environment in which to provide technical support.
“I’m looking forward to exploring how my experience can be most useful in supporting Animalcare’s expansion and, more importantly, ensuring that the company’s customers receive the guidance and advice they need to optimise the effectiveness of Animalcare’s product range in treating their patients.”
For technical support, email: technical@animalcare.co.uk
The study, titled The Veterinary Employment, Engagement and Retention Study (VEER), opened this week and aims to collect data from thousands of veterinary professionals across the United Kingdom and beyond.
Dr Dermot McInerney (pictured right), VetX Head of Research and Partnerships, said: “We will use the data collected to understand the factors influencing career happiness and how they impact on talent attraction and retention.
"We want to share this information with as many people as possible so we can work together to create a better, more sustainable situation for both employers and employees in veterinary practice.”
The study findings will be published later in 2022 and made available to all industry stakeholders.
All participants will receive a special report of the results with customised career advice, and be entered into a weekly draw to win a prize.
To take part in the survey, visit: www.vetxinternational.com/veer.
The veterinary group is stumping up more than £100,000 for the initiative, which will enable 20 vets and nurses, and 56 new grads from across the group to work with the Worldwide Veterinary Service (WVS) and other overseas animal charities.
The grants are for £1,500 and those taking part will also get up to one week of paid time off work whilst they volunteer.
VetPartners CEO Jo Malone said: “We wanted to support colleagues to have a fantastic experience while improving their skills in a different environment.
"It will give people a chance to use their clinical skills to give back to charities which are doing great work.
“If you’re working in a veterinary practice in Europe, you have support from team members around you and great facilities and equipment compared to the more challenging conditions working for a charity overseas.
"Working in these more challenging environments while they are volunteering will help build resilience, as our team members are unlikely to have experienced anything like this before.
“Charities like the World Veterinary Service are working ethically to help animals that may or may not have ever had veterinary care, and are doing a great job so we are delighted to support them.”
Merial has announced that a recent change of licence means you can now administer the new generation NSAID, Previcox® for the relief of post operative pain associated with soft tissue and orthopaedic surgery in dogs.
Mark Riggs MRCVS, Veterinary Technical Advisor for Merial said: "Previcox (firocoxib) is now licensed for the relief of post operative pain. Oral PREVICOX can be administered starting 2 hours prior to surgery and has a rapid onset of action reaching peak plasma levels within 90 minutes. The palatable tablet can be given without food and is a realistic option which should be seriously considered when choosing pain relief for surgical patients.
"Containing the active ingredient firocoxib, Previcox is also highly COX-2 selective, being 380 times more selective for COX-2 than COX-1. As a result, it offers a highly desirable efficacy and safety profile which is particularly beneficial in cases which have gone through the additional stress of surgery.
"The recently published study by John P. Punke et al strengthens the evidence reinforcing the benefits offered by firocoxib. The research evaluated the in-vivo effects of firocoxib, meloxicam and tepoxalin in target tissues of dogs suffering with chronic osteoarthritis.
"Eight dogs were used in the cross-over study and each dog received each of the treatments (and a placebo) for seven days, with an appropriate wash out period in between. Firocoxib significantly reduced inflammatory mediators within blood and synovial fluid at all time points, whereas meloxicam only showed a significant reduction compared to baseline values at day four.
"With evidence demonstrating the speed of the anti-inflammatory effect of firocoxib, it may be time for vets to reconsider their post operative pain management. Previcox can be administered orally prior to surgery and can be given once daily for up to three days post operatively. For orthopaedic surgery this treatment schedule can be extended after the first 3 days upon judgement of the attending vet."
For further information please contact your local territory manager or call the Merial Customer Support Centre on 0845 601 4236.
DG Sanco, the EU Directorate General for Health and Consumers, has launched a worldwide photo competition to mark World Vet Year: 'Vets in your daily life'
Entries need to be photos of a vet (or vets) at work or in any situation which shows the diverse nature of the job. Five winners will win 1000 Euros worth of photographic equipment. The overall winner will win an additional 2000 Euros worth of photographic equipment. All winners will also be given travel and accommodation for the awards ceremonies in Paris and Brussels.
Anyone (except for employees of the European Institutions, and their families) can enter the competition, which closes on 31st March 2011. More details can be found at: www.vetsinyourdailylife.org.
Here's the promotional video for the competition:
Davies Veterinary Specialists has announced that it will be launching a new referral service in the heart of London at an event being held at the Institute of Physics at 7:00pm on 15th February.
As part of the preparations, the multi-discipline referral centre has published a very polished video which you can view here.
The launch event includes some free CPD: "Challenges in Urology", together with drinks and nibbles.
The Royal College of Veterinary Surgeons has announced that Nick Stace has been appointed its Chief Executive and Secretary, and will take up his post on 3 September 2012.
Mr Stace leaves CHOICE, Australia's equivalent of consumer group Which?, after three and a half years as Chief Executive Officer. At CHOICE, Nick led the modernisation of the organisation, this year taking it to the number one spot as the most trusted media entity in Australia. A long-standing consumer champion, Nick also held the post of Deputy CEO at Which?, he was a director at Consumers' International and former Prime Minister Gordon Brown's Director of Strategic Communications.
RCVS President Jerry Davies said: "I am delighted that Nick Stace will be joining the College. With his impressive track-record, I believe that we have a Chief Executive who will lead the College into a new phase of modernisation and development. I am grateful to the Interview Panel, led by Council member Dr Barry Johnson, for all their hard work in securing this excellent appointment."
Nick Stace said: "It is an enormous privilege to be leading an organisation that seeks to ensure Britain has the best vets in the world. The College has a special place in the lives of every vet in the country, it also has a responsibility to animals and consumers to set high standards and ensure they are met. I look forward to helping the College continue to improve veterinary standards across the country and to lead the College through its next stage of development."
The role of Chief Executive and Secretary is a new one - previously the Registrar led the executive of the College. One of Nick Stace's first tasks will be to assist in recruitment of the Head of Legal Services/Registrar, a new role.
Scientists at the University of Liverpool have, for the first time, revealed that digital dermatitis (DD) has been present on hoof knifes used on cattle and sheep following research1 jointly funded by DairyCo and EBLEX.
The research conducted at the University investigated if DD Treponeme can be present on equipment used to trim cattle and sheep hooves. The research team, led by Dr Nicholas Evans and Professor Stuart Carter of the University of Liverpool and in collaboration with Roger Blowey MRCVS, tested trimming equipment used on cattle and sheep with digital dermatitis and after it was disinfected.
After trimming, DD was present on 97% of cattle blades and 100% of sheep blades. This was reduced to 29% and 46% respectively after disinfection.
Dr Evans said: "It has long been considered that digital dermatitis was spread in slurry which we have some evidence for and are continuing to investigate but now, for the first time, we have discovered the digital dermatitis bugs in the farm environment.
"However, the high detection rate of digital dermatitis bacteria on trimming blades soon after trimming cattle and sheep hooves from digital dermatitis cases suggests this may be a significant and worrying route for the transmission of this infectious condition."
Leigh Sullivan, who conducted the field work as part of her study, said: "Interestingly, in the world of human dentistry, a completely different species of the bacteria is found to cause gum disease. Furthermore, studies have shown it will adhere to metal on orthodontic braces which is consistent with our detection of the digital dermatitis Treponeme on metallic trimming knives."
Dr Jenny Gibbons, DairyCo research & development manager, added: "This DairyCo and EBLEX-funded study could help farmers, vets and hoof trimmers to understand more about the transmission of digital dermatitis between cows and farms. A logical precaution to limit the spread is to disinfect hoof trimming equipment between animals and between farms."
To find out more about this and other R&D projects, DairyCo is hosting a research day on 17 July at Trenault Farm, Launceston, Cornwall.
To book a place, visit: dairyco.org.uk/researchday2014
Reference
Preliminary results, which recorded a decline in the quantities of antimicrobials prescribed from 2014 to 2018, were published in 2022.
A further audit has now been undertaken in all 22 of the company's first opinion practices to investigate the age, breed and estimated weight of each horse, the clinical indication for antibiotic use, the drugs prescribed, their dose rates, the route of administration and whether culture and sensitivity were used to guide antimicrobial selection.
Data collection was completed in August 2022.
This secondary audit was conducted using a ‘point prevalence’ survey, in which each CVS Equine first opinion Quality Improvement Lead gathered information about all systemic antibiotics prescribed by each of their practices on one day a month for 12 consecutive months.
The project yielded information on 331 cases where systemic antimicrobials were prescribed.
Complete data about the first line-drug selection were available for 261 prescriptions.
The commonest prescribed antimicrobial was sulfadiazine/trimethoprim (41%), followed by oxytetracycline (23%), procaine penicillin (16%), doxycycline (13%), gentamicin (4%), metronidazole (1%), ceftiofur (1%) and enrofloxacin (1%).
Highest priority critically important antimicrobials (ceftiofur and enrofloxacin) were only prescribed in four horses (clinical indications for these included possible sepsis, skin infection, lower respiratory tract infection and a wound complication – in none of these cases was the first-line drug selection based on the results of culture and sensitivity.
Overall, the clinical indications for antimicrobial use were recorded in 246 cases; the commonest indications were cellulitis/lymphangitis (27%), uncomplicated wounds (19%), surgical prophylaxis (15%), respiratory infections (11%) and skin infections (8%).
Hattie Lawrence, Director of CVS Equine, said: “Though the impact of this work is yet to be documented, there is anecdotal evidence that it has raised awareness amongst our veterinarians of the importance of antimicrobial stewardship.
"Taken together, the results of both pieces of work will be used to help develop and inform clinical audits and clinical guidelines of antimicrobial use in horses.”
Virbac has announced a special promotion in which practices can earn a specialist ear instrument kit worth £100
The kit, which has been designed by Virbac vets in consultation with a number of veterinary dermatologists, is available with multiple purchases of the otitis treatment EasOtic, and the neutral pH glycotechnology ear cleaner Epi-Otic.
Product manager Chris Geddes MRCVS said: "Each kit contains a haemostat, ear forceps, 3 various cerumen scoops and a Spreulls ear-flushing needle. Basically it's the best ear equipment for daily use by practitioners. For a limited period we are giving away one set FOC with every purchase of 25 bottles of EasOtic and 25 bottles of Epi-Otic."
Chris added: "When it comes to treatment of otitis, we know that client compliance is a key issue. The award-winning design of EasOtic makes it an extremely easy product to use. The 'one pump' delivery system helps deliver more accurate dosing and minimises animal stress during application. This means that treatment courses are more likely to be completed, thus optimising results and client satisfaction all round."
For further information, please contact your local Virbac territory manager or call Virbac on 01359 243243.
Petlog is announcing details of National Microchipping Month at BSAVA, which this year will include a special offer through which pet owners can update their registered details free of charge, and a 10% discount on SureFlap microchip cat flaps to all veterinary practices that agree to stock SureFlap and take part in the June initiative.
Celia Walsom, Petlog Executive said: "On top of the launch of National Microchipping Month 2011 we will be releasing details about the 'Petlog's Featured Practice' competition, our social media campaign enabling veterinary practices to send in images of themselves with their happy customers: selected images will be featured online and there will be a unique prize for the overall winners.
She added: "Visitors to the Petlog stand will also be able to pick up their own personal copy of the Kennel Club's Veterinary Practice Guide to Dog Health on a handy disk."
Meanwhile, you can see SureFlap on stand 203 at Congress or visit: www.sureflap.co.uk/trade.
The 2022 programme will include 17 education streams, covering the veterinary and nursing care of companion animals, together with a stream covering veterinary wellness, leadership and management-related topics.
Speakers include veterinary experts and leaders from around the world, and the expected 2,000+ delegates will be able to collect 14 hours of CPD over the two days.
The VET Festival will also offer a Wellness Hub offering things like yoga, movement and mindfulness sessions alongside the lectures.
There'll be a diverse commercial exhibition, with more than 60 leading veterinary suppliers, and all delegates will also have free admission to the VETFest Live Party Night.
Noel Fitzpatrick, Clinical Chair at Fitzpatrick Referrals, who launched VET Festival in 2015, said: “The last 18 months have been tough for everyone but particularly difficult for veterinary professionals, many of whom were already suffering with challenges to their well-being and mental health because of the pressures of their work.
"VET Festival is an oasis of time during which they can relax and rejuvenate themselves; experiencing continuing professional development that is uplifting and inclusive and enjoying social activities and companionship that will replenish their souls.”
Tickets for VET Festival can be bought here: https://www.vetfestival.co.uk/delegate-info/ticket-information
The service will be run by Dr Eloise Quince BVetMed CertAVP(SAM-F) PgCertVPS MANZCVS MRCVS and Dr Kate Allgood BVetMed CertAVP(SAM) MRCVS.
The practice says radioactive iodine therapy is the treatment of choice for hyperthyroid cats as it provides a permanent cure in up to 95% of cases.
It is administered by an iodine injection under the skin in a specialised unit by a trained vet and nurse.
The practice says a benefit of RI is that it treats ‘ectopic tissue’ that may be present outside of the thyroid gland, for example in the chest, which is not treated by surgical methods of thyroid removal.
Normal thyroid tissue is also spared, so that there is normal thyroid function post-treatment.
Though some blood tests need to be taken post-treatment, there is no need for ongoing blood samples and the monitoring of the thyroid function once successful treatment has occurred.
Elissa Norman, Clinical Director, who initially developed the idea for the iodine unit said: “The iodine unit first started as a scribble on a piece of paper and a dream of our team back in 2017 and it has taken a huge amount of dedication and effort from a large team of people to get to the point of opening in 2023.
"Radioactive iodine offers a lifetime cure for our hyperthyroid cats and we are delighted to be able to bring this service to the cats of East Anglia.”
To refer a cat patient, vets should email iodine@veterinary-hospital.co.uk.
The survey of 50 vets carried out in May this year1 found that only half of them are recommending strangles vaccination to their clients.
They also felt that horse owners could be doing more to combat the disease.
Less than half of vets questioned believed that yards and premises operated good biosecurity measures prior to a strangles outbreak, yet 85% brought in more stringent biosecurity after an outbreak, when it was too late.
Dechra says that vets and horse owners can help combat the estimated 300 outbreaks of strangles each year with the following steps:
Sara Barker BVSc CertAVP(EM) MRCVS, equine field support manager at Dechra, said: “Strangles is one of the most common equine infectious diseases both in the UK and worldwide and a multi-factor approach is key to tackling the disease.
"Strangles vaccination is recommended, alongside good biosecurity, quarantine measures and regular temperature checking.
"By working together, vets and horse owners can help to keep horses healthy and prevent the spread of strangles.”